More about

Ulcerative Colitis

News
April 26, 2024
7 min read
Save

Family planning in IBD: ‘It is our responsibility’ to share accurate resources, support

Family planning in IBD: ‘It is our responsibility’ to share accurate resources, support

A young woman, newly diagnosed with inflammatory bowel disease, sits in your office.

News
April 24, 2024
2 min read
Save

Budesonide does not affect engraftment, clinical response after FMT in ulcerative colitis

Budesonide does not affect engraftment, clinical response after FMT in ulcerative colitis

Pretreatment with budesonide did not significantly influence engraftment among patients with ulcerative colitis who underwent fecal microbiota transplantation, with researchers reporting that clinical response appeared to be donor-dependent.

News
April 17, 2024
5 min read
Save

‘Efficacy will lead’ as first-line JAK inhibitor use picks up in moderate to severe UC

‘Efficacy will lead’ as first-line JAK inhibitor use picks up in moderate to severe UC

Despite a class-wide black box warning for prescribing in the early setting, 31% of providers reported positioning Janus kinase inhibitors as first-line treatment among patients with severe ulcerative colitis, according to survey results.

News
April 15, 2024
2 min read
Save

Benefit of biosimilar switching ‘less apparent’ to GIs, patients vs. third-party payers

Benefit of biosimilar switching ‘less apparent’ to GIs, patients vs. third-party payers

If you see more than a few patients with inflammatory bowel disease, you likely already have been asked by a third-party payer to switch a patient’s adalimumab prescription from the reference product to a biosimilar.

News
April 15, 2024
11 min read
Save

Interchangeable biosimilars may cut costs or cause ‘cognitive dissonance’

Interchangeable biosimilars may cut costs or cause ‘cognitive dissonance’

The age of biosimilars has come for gastroenterology. This includes interchangeable products, three of which are now on the market. How this will impact patient care in the near and distant future is the subject of much speculation.

News
April 10, 2024
2 min read
Save

Better efficacy outcomes associated with infliximab vs. vedolizumab in Crohn’s disease

Better efficacy outcomes associated with infliximab vs. vedolizumab in Crohn’s disease

Induction and maintenance treatment with infliximab was more efficacious than vedolizumab in patients with Crohn’s disease, while efficacy was similar between the two therapies in patients with ulcerative colitis, according to data.

News
April 09, 2024
2 min read
Save

Female sex, genetics, smoking status linked to extraintestinal manifestation in IBD

Female sex, genetics, smoking status linked to extraintestinal manifestation in IBD

Female sex, smoking, Crohn’s disease and a history of surgery to treat inflammatory bowel disease were associated with an increased risk for developing extraintestinal manifestations of disease, according to research in Gastroenterology.

News
March 11, 2024
5 min watch
Save

VIDEO: Roundtables invite young adults with IBD to ‘have equal voices’ on research, care

VIDEO: Roundtables invite young adults with IBD to ‘have equal voices’ on research, care

In a Healio video exclusive, Sneha Dave, recaps a roundtable series presented by the Crohn’s and Colitis Young Adults Network, which encourages young adults with inflammatory bowel disease to discuss gaps and opportunities in research.

News
March 07, 2024
6 min watch
Save

VIDEO: Inflammation likely ‘driving the risk’ for cardiovascular events in IBD

VIDEO: Inflammation likely ‘driving the risk’ for cardiovascular events in IBD

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses data he presented at the GUILD Conference, which show patients with inflammatory bowel disease are at increased risk for cardiovascular events, likely driven by inflammation.

News
March 07, 2024
2 min read
Save

AGA: ‘We must work together’ to alleviate barriers, improve care for patients with IBD

AGA: ‘We must work together’ to alleviate barriers, improve care for patients with IBD

A 12-point plan from the AGA proposed ways in which collaboration between the health care community, insurers, pharmaceutical companies and legislators can improve “fixable problems” affecting patients with inflammatory bowel disease.

View more